1.Fu K, Zhang H, Chen N, Hu Y, Xiao J, Zhang X, Lin Z, Lu H*, Ji X*.Risk factors for intracardiac thrombus in peripartum cardiomyopathy: a retrospective study in China.ESC Heart Fail.2022 Sep 21.（*通讯作者）
2.Zhang X*, Wang Y, Chen N, Liu Y, Xiao J, Lin Z, Lu H*, Ji X*. Red cell distribution width is associated with short-term mortality in critically ill patients with heart failure.ESC Heart Fail.2022 Jun 29. Online ahead of print.（*通讯作者）
3.Zhang X, Sun Y, Zhang H, Lu H, Ji X*. The Relationship Between the Utilization of Arterial Blood Gas Analysis and Rehospitalization in Heart Failure: A Retrospective Cohort Study.Front Cardiovasc Med.2022 Apr 26;9:847049. （*通讯作者）
4.Cui, S#;Lu, H#; Wei, S#; Li, C; Xu, F; Chen, Y. The PIEZO1 gene mutation (c.2005G>T) causesiron overload cardiomyopathy: a case report.Emergency and Critical Care Medicine.1(2):86-89, December 2021.
5.Fu K, Hu Y, Zhang H, Wang C, Lin Z, Lu H* , Ji X* . Insights of worsening renal function in type 1 cardiorenal syndrome: from the pathogenesis, biomarkers to treatment.Front. Cardiovasc. Med. 2021 Dec 14, 8:760152（*通讯作者）
6.Zhang X, Wang L, Guo R, Xiao J, Liu X, Dong M, Luan X, Ji X, Lu H. Ginsenoside Rb1 Ameliorates Diabetic Arterial Stiffening via AMPK Pathway.Front Pharmacol. 2021 Oct 12;12:753881.（*通讯作者）
7.Yang X#, Wang L#, Zhang Z, Hu J, Liu X, Wen H, Liu M, Zhang X, Dai H, Ni M, Li R, Guo R, Zhang L, Luan X, Lin H, Dong M*,Lu H*.Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF.Front. Cardiovasc. Med.,28 May 2021;8:654670.（*通讯作者）
8.Zhou P, Zhang X, Guo M, Guo R, Wang L, Zhang Z, Lin Z, Dong M, Dai H, Ji X*,Lu H*. Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway.J Cell Mol Med.2019 Oct;23(10):7088-7098 （*通讯作者）
9.Zeng X#, Guo R, Dong M, Zheng J, Lin H*,Lu H*.Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression,J Transl Med.2018 Apr 19;16(1):106. doi: 10.1186/s12967-018-1479-6.（*通讯作者）
10.Zhang X#, Liu MH#, Qiao L, Zhang XY, Liu XL, Dong M, Dai HY, Ni M, Luan XR, Guan J*,Lu HX*. Ginsenoside Rb1 enhancesatherosclerotic plaque stabilization by skewing macrophages to the M2 phenotype,J Cell Mol Med, 2018 Jan;22(1):409-416. 2017 Sep 25.（*通讯作者）
11.Lu H#,Zhou X#, Kwok HH, Dong M, Liu Z, Poon PY, Luan X, Ngok-Shun Wong R*. Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway.Front Pharmacol.2017 Nov 13;8:783.
12.Qiao L#, Zhang X#, Liu M, Liu X, Dong M, Cheng J, Zhang X, Zhai C, Song Y,Lu H*, Chen W*. Ginsenoside Rb1 Enhances Atherosclerotic Plaque Stability by Improving Autophagy and Lipid Metabolism in Macrophage Foam Cells.Front Pharmacol.2017 Oct 24;8:727.（*通讯作者）
13.Yang X#, Dong M#, Wen H, Liu X, Zhang M, Ma L, Zhang C, Luan X,Lu H*, Zhang Y*. MiR-26a Contributes to the PDGF-BB-induced Phenotypic Switch of Vascular Smooth Muscle Cells by Suppressing Smad1,oncotarget,2017 May 18;8(44):75844-75853.（*通讯作者）
14.Liu M#, Wang L, Wen H,Lu H*. Response to letter "Does PEDF improve atherosclerotic plaque stability by inhibiting VSMCs apoptosis".Int J Cardiol. 2017 Sep 1;242:12. （*通讯作者）letter
15.Wen H#, Liu M#, Liu Z, Yang X, Liu X, Ni M, Dong M, Luan X, Yuan Y, Xu X*, and Lu H*.PEDF Improves Atherosclerotic Plaque Stability by Inhibiting Macrophage Inflammation Response.Int J Cardiol. 2017 May 15;235:37-41.（*通讯作者）
